Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 ...

1 at population level. Our findings reveal the heterogeneous hybrid immunity against SARS-CoV-2 over 11 months following breakthrough infection, ...

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection.

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 ...

This study indicates heterogeneous hybrid immunity over 11 months post-BTI, and underscores the vulnerability of individuals, particularly high-risk seniors, ...

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 ...

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection-article.

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 ...

Download Citation | Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection | A highly ...

[PDF] Heterogeneous hybrid immunity against Omicron variant JN.1 ...

Heterogeneous hybrid immunity over 11 months post-BTI is indicated, which underscores the vulnerability of individuals, particularly high-risk seniors, to ...

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 ...

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection ; Journal ID (nlm-ta): Signal Transduct Target Ther.

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 ...

Meanwhile, XBB/EG.5-wave reinfection post-BTI significantly boosted the neutralizing antibodies against Omicron variants, including JN.1 in both adults (13.4- ...

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 ...

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection. Xuan He,; Jingyou Yu,; Jiajing Jiang,; Jinyuan Liu, ...

SciencesNetwork on X: "Heterogeneous hybrid immunity against ...

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection https://t.co/h9MWDzhxQG.

Prof. Dr. Sanjeev Bagai on X: "Heterogeneous hybrid immunity ...

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following BTI: JN.1 signif⬆its resistance to Abs response against SARSCoV2 by ...

Signal Transduct Target Ther . Heterogeneous hybrid immunity ...

Signal Transduct Target Ther . 2024 Jul 19;9(1):180. doi: 10.1038/s41392-024-01898-x. Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 ...

Heterogeneity of SARS-CoV-2 immune responses after the ...

Furthermore, nAbs against Omicron variants lasted longer than nAbs against WT SARS-CoV-2. Breakthrough infections of Omicron variants elicited ...

Nicolas Castillo on LinkedIn: Heterogeneous hybrid immunity ...

Heterogeneous Hybrid Immunity Against Omicron Variant JN.1 at 11 Months Following Breakthrough Infection A recent study has explored the nature of hybrid…

Marc Veldhoen - X

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection No, not waning "immunity" waning ...

COVID-19 Research Library | Search - Outbreak.info

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection ... Xuan He et al. bioRxiv. published 2024-03-04.

Changes in Population Immunity Against Infection and Severe ...

Between 1 December 2021 and 9 November 2022, protection against a new Omicron infection rose from 22% (21%–23%) to 63% (51%–75%) nationally, and protection ...

1 Executive Summary Updated Risk Evaluation of JN.1, 15 April 2024

1 Variants in Immune Evasion,. Antigenicity and Cell-Cell Fusion ... Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 ...

Neutralization of SARS‐CoV‐2 Omicron XBB.1.5 and JN.1 variants ...

1.5 and JN.1. after infections with earlier Omicron variants. These findings show that SARS-CoV-2-immunity is heterogeneous, depending on ...

Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review ...

The fact that immune boosting offered by Omicron infection seems to be affected by the type of previous SARS-CoV-2 exposure triggered hypotheses about the ...